Patents by Inventor Nozomi Yamaguchi
Nozomi Yamaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230250589Abstract: An oil-resistant agent and an oil-resistant composition, which are capable of imparting excellent oil-resistance to paper. The oil-resistant composition contains a polysaccharide (1) and an oil-resistant polymer (2). The polysaccharide (1) is preferably starch. The oil-resistant polymer (2) preferably has (a) a repeating unit formed from an acrylic monomer that has a long-chain hydrocarbon group having 7-40 carbon atoms, and (b) a repeating unit formed from an acrylic monomer that has a hydrophilic group. A polyvinyl alcohol or glucose may be present as an additive.Type: ApplicationFiled: April 13, 2023Publication date: August 10, 2023Applicant: DAIKIN INDUSTRIES, LTD.Inventors: Michio MATSUDA, Hirotoshi SAKASHITA, Nozomi YAMAGUCHI, Tetsuya UEHARA, Daisuke NOGUCHI, Shun SHIBATA
-
Publication number: 20230220140Abstract: An oil-resistant agent containing an amide compound including a bio-based material modified with a long-chain hydrocarbon group having 7 to 40 carbon atoms and an amide group. Also disclosed is a fiber product containing the amide compound, and a water dispersion containing the amide compound.Type: ApplicationFiled: March 22, 2023Publication date: July 13, 2023Applicant: DAIKIN INDUSTRIES, LTD.Inventors: Shun SHIBATA, Tetsuya Uehara, Daisuke Noguchi, Nozomi Yamaguchi, Shinichi Minami, Teruyuki Fukuda
-
Patent number: 7282579Abstract: There are provided a polynucleotide encoding human BSSP6 serine protease and a vector and transformed host cells containing this human BSSP6 serine protease encoding polynucleotide.Type: GrantFiled: February 14, 2005Date of Patent: October 16, 2007Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 7211425Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP4; an antibody against BSSP4; and a method for detecting BSSP4 in a specimen by using the antibody.Type: GrantFiled: June 29, 2006Date of Patent: May 1, 2007Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Publication number: 20060239994Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP4; an antibody against BSSP4; and a method for detecting BSSP4 in a specimen by using the antibody.Type: ApplicationFiled: June 29, 2006Publication date: October 26, 2006Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 7029909Abstract: A protein expression vector containing (a) a nucleotide sequence encoding an IgG(?) or a trypsin secretory signal peptide, (b) a nucleotide sequence encoding a polyhistidine amino acid sequence, (c) a nucleotide sequence encoding an amino acid sequence comprising amino acid residues 36–40 of SEQ ID NO:19 (Asp-Asp-Asp-Asp-Lys), which is cleavable by an enterokinase, and (d) a cloning site into which a nucleotide sequence encoding a target protein can be inserted, wherein (a), (b), (c) and (d) are assembled within the vector in the order recited.Type: GrantFiled: November 19, 1999Date of Patent: April 18, 2006Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 6998245Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2 and 4; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP5; an antibody against BSSP5; and a method for detecting BSSP5 in a specimen by using the antibody. The BSSP5 provied by the present invention can be used for treating and diagnosing various diseases such as Alzheimer's disease (AD), epilepsy, cancer, inflammation, sterility and prostatic hypertropy and detecting pancreatitis in various tissues including brain, prostate gland, placenta, pancreas and spleen.Type: GrantFiled: November 19, 1999Date of Patent: February 14, 2006Assignee: FUSO Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Publication number: 20050170415Abstract: There are provided a human BSSP6 serine protease and a pharmaceutical composition containing this serine protease. Also provided is an antibody to this serine protease or to a fragment thereof.Type: ApplicationFiled: February 14, 2005Publication date: August 4, 2005Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Publication number: 20050165223Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2, 4, 6, 8 and 10; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP2; an antibody against BSSP2; and a method for detecting BSSP2 in a specimen by using the antibody.Type: ApplicationFiled: March 24, 2005Publication date: July 28, 2005Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 6921658Abstract: There are provided a human BSSP6 serine protease and a pharmaceutical composition containing this serine protease. Also provided is an antibody to this serine protease or to a fragment thereof.Type: GrantFiled: November 19, 1999Date of Patent: July 26, 2005Assignee: Fuso Pharmacutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 6908756Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2, 4, 6, 8 and 10; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP2; an antibody against BSSP2; and a method for detecting BSSP2 in a specimen by using the antibody.Type: GrantFiled: November 19, 1999Date of Patent: June 21, 2005Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Publication number: 20050053983Abstract: There are provided proteins having the amino acid sequences represented by SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20; proteins having amino acid sequences derived from these amino acid sequences by deletion, substitution or addition of one to several amino acids; and nucleotide sequences encoding the same; transgenic non-human animals with altered expression level of a serine protease BSSP4; an antibody against BSSP4; and a method for detecting BSSP4 in a specimen by using the antibody.Type: ApplicationFiled: November 16, 2004Publication date: March 10, 2005Applicant: Fuso Pharmaceutical Industries, Ltd.Inventors: Hidetoshi Uemura, Akira Okui, Katsuya Kominami, Nozomi Yamaguchi, Shinichi Mitsui
-
Patent number: 6645734Abstract: A monoclonal antibody binding selectively to neurosin obtained from hybridomas, in particular, strain 2B2-6 and strain S2E5 showing stable proliferation ability. These hydridomas are obtained by fusing mouse spleen cells having a high antibody titer against neurosin with mouse-derived myeloma cells, screening fused cells being highly reactive with neurosin, and thus producing an antibody binding specifically to neurosin. By using this antibody, various diseases in which neurosin participates can be diagnosed.Type: GrantFiled: December 21, 2000Date of Patent: November 11, 2003Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Katsuya Kominami, Akira Okui, Shinichi Mitsui, Nozomi Yamaguchi
-
Publication number: 20020164711Abstract: A novel megakaryocyte differentiation factor, for example, consisting essentially of SEQ ID NO: 30; DNA coding for the megakaryocyte differentiation factor, an expression vector comprising the DNA, a host transformed with the expression vector, and a process for production of the megakaryocyte differentiation factor using the host.Type: ApplicationFiled: March 7, 2002Publication date: November 7, 2002Inventors: Masafumi Tsujimoto, Fuyuki Iwasa, Nobuo Tsuruoka, Hiroshi Nakazato, Kenju Miura, Nobuhiro Ishida, Tatsuya Kurihara, Kozo Yamaichi, Nozomi Yamaguchi
-
Publication number: 20020160490Abstract: The present invention discloses a serine protease or its partial peptide containing an amino acid sequence identical to serine protease indicated in SEQ ID NO: 6, an amino acid sequence in which a portion of the identical amino acid sequence is deleted or substituted, or an amino acid sequence in which at least one amino acid is added to the identical amino acid sequence or an amino acid sequence in which a portion of the identical amino acid sequence is deleted or substituted.Type: ApplicationFiled: March 24, 1999Publication date: October 31, 2002Inventors: NOBUO TSURUOKA, KYOKO YAMASHIRO, NOZOMI YAMAGUCHI
-
Publication number: 20010026931Abstract: A novel megakaryocyte differentiation factor, for example, consisting essentially of SEQ ID NO: 30; DNA coding for the megakaryocyte differentiation factor, an expression vector comprising the DNA, a host transformed with the expression vector, and a process for production of the megakaryocyte differentiation factor using the host.Type: ApplicationFiled: August 26, 1998Publication date: October 4, 2001Inventors: MASAFUMI TSUJIMOTO, FUYUKI IWASA, NOBUO TSURUOKA, HIROSHI NAKAZATO, KENJU MIURA, NOBUHIRO ISHIDA, TATSUYA KURIHARA, KOZO YAMAICHI, NOZOMI YAMAGUCHI
-
Publication number: 20010016331Abstract: A monoclonal antibody binding selectively to neurosin obtained from hybridomas, in particular, strain 2B2-6 and strain S2E5 showing stable proliferation ability. These hydridomas are obtained by fusing mouse spleen cells having a high antibody titer against neurosin with mouse-derived myeloma cells, screening fused cells being highly reactive with neurosin, and thus producing an antibody binding specifically to neurosin. By using this antibody, various diseases in which neurosin participates can be diagnosed.Type: ApplicationFiled: December 21, 2000Publication date: August 23, 2001Inventors: Katsuya Kominami, Akira Okui, Shinichi Mitsui, Nozomi Yamaguchi
-
Patent number: 5972886Abstract: A novel megakaryocyte differentiation factor, for example, consisting essentially of SEQ ID NO: 30; DNA coding for the megakaryocyte differentiation factor, an expression vector comprising the DNA, a host transformed with the expression vector, and a process for production of the megakaryocyte differentiation factor using the host.The megakaryocyte differentiation factor accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelete.Type: GrantFiled: March 6, 1996Date of Patent: October 26, 1999Assignee: Suntory LimitedInventors: Masafumi Tsujimoto, Fuyuki Iwasa, Nobuo Tsuruoka, Hiroshi Nakazato, Kenju Miura, Nobuhiro Ishida, Tatsuya Kurihara, Kozo Yamaichi, Nozomi Yamaguchi
-
Patent number: 5874253Abstract: A novel megakaryocyte differentiation factor, for example, consisting essentially of SEQ ID NO: 30; DNA coding for the megakaryocyte differentiation factor, an expression vector comprising the DNA, a host transformed with the expression vector, and a process for production of the megakaryocyte differentiation factor using the host. The megakaryocyte differentiation factor accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelete.Type: GrantFiled: June 7, 1995Date of Patent: February 23, 1999Assignee: Suntory LimitedInventors: Masafumi Tsujimoto, Fuyuki Iwasa, Nobuo Tsuruoka, Hiroshi Nakazato, Kenju Miura, Nobuhiro Ishida, Tatsuya Kurihara, Kozo Yamaichi, Nozomi Yamaguchi
-
Patent number: 5834284Abstract: A .beta.1,6-N-acetylglucosaminyl transferase having the following properties:(1) Action: it transfers N-acetylglucosamine from UDP-N-acetylglucosamine to .alpha.-6-D-mannoside;(2) Substrate specificity: it shows a reactivity of about 79% for GnGnF-bi-PA, about 125% for GnGnGn-tri-PA and about 66% for GnM-Pa, when taking a reactivity for GnGn-bi-PA as 100%;(3) Optimum pH: 6.2 to 6.3;(4) Inhibition, Activation and Stability: Mn.sup.2+ is not necessary for expression of activity, and the activity is not inhibited in the presence of 20 mM EDTA;(5) Molecular weight: about 73,000 as determined by SDS-PAGE in the absence of reducing agent; and about 73,000 and about 60,000 as determined in the presence of a reducing agent;(6) Km value: 133 .mu.M and 3.Type: GrantFiled: August 14, 1997Date of Patent: November 10, 1998Assignee: Suntory LimitedInventors: Naoyuki Taniguchi, Atsushi Nishikawa, Nozomi Yamaguchi